Schedule 13G ownership disclosure
NEKTAR THERAPEUTICS
Security class unavailable · CUSIP: 640268108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 18,511,911
- Percent of class
- 10.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-002624
- Form type
- SC 13G
- Filer
- NEKTAR THERAPEUTICS
- CIK
- CIK 906709
- Filed
- Jan 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership